With the continuous approval of gene therapy products into the clinical research, the viral vectors which are used for gene therapy have attracted extensive attention. Adeno-associated virus is the most promising viral vector of many other viral vectors because of its low pathogenicity, low immunogenicity and the advantage of the host range and stable expression. It has gotten a wide range of applications in clinical research.
There are multiple strategies to develop AAV vectors, but typical steps include plasmid development and production, cell expansion, plasmid transfection, viral vector production, purification, and fill and finish. A transient transfection strategy for AAV production in either adherent or suspension cell lines is most common in pre-clinical and early phase development.
Global AAV Vector Transfection Kits include Thermo Fisher, Mirus Bio (Gamma), Polyplus-transfection, Polysciences, Takara and Hanbio Biotechnology, etc. Global top 3 companies hold a share over 70%. North America is the largest market, with a share about 49%, followed by Europe and Asia Pacific with the share about 26% and 21%.
The global AAV Vector Transfection Kits market was valued at US$ 57 million in 2020 and is expected to reach US$ 322.8 million by the end of 2027, growing at a CAGR of 25.9% during 2021-2027.
This report focuses on AAV Vector Transfection Kits volume and value at the global level, regional level and company level. From a global perspective, this report represents overall AAV Vector Transfection Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global AAV Vector Transfection Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
by Packaging Size
Small Size Packaging
Medium Size Packaging
Large Size Packaging
by Phase
Laboratory
GMP Phase 1-2
Segment by Application
Suspension HEK 293 Cells
Adherent HEK 293 Cells
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Thermo Fisher
Mirus Bio (Gamma)
Polyplus-transfection
Polysciences
Takara
Hanbio Biotechnology
There are multiple strategies to develop AAV vectors, but typical steps include plasmid development and production, cell expansion, plasmid transfection, viral vector production, purification, and fill and finish. A transient transfection strategy for AAV production in either adherent or suspension cell lines is most common in pre-clinical and early phase development.
Global AAV Vector Transfection Kits include Thermo Fisher, Mirus Bio (Gamma), Polyplus-transfection, Polysciences, Takara and Hanbio Biotechnology, etc. Global top 3 companies hold a share over 70%. North America is the largest market, with a share about 49%, followed by Europe and Asia Pacific with the share about 26% and 21%.
The global AAV Vector Transfection Kits market was valued at US$ 57 million in 2020 and is expected to reach US$ 322.8 million by the end of 2027, growing at a CAGR of 25.9% during 2021-2027.
This report focuses on AAV Vector Transfection Kits volume and value at the global level, regional level and company level. From a global perspective, this report represents overall AAV Vector Transfection Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global AAV Vector Transfection Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
by Packaging Size
Small Size Packaging
Medium Size Packaging
Large Size Packaging
by Phase
Laboratory
GMP Phase 1-2
Segment by Application
Suspension HEK 293 Cells
Adherent HEK 293 Cells
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Thermo Fisher
Mirus Bio (Gamma)
Polyplus-transfection
Polysciences
Takara
Hanbio Biotechnology
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.